☆ 4.3 Editorial Material

Repeated infusion of autologous adipose tissue-derived stem cells for Parkinson's disease

ACTA NEUROLOGICA SCANDINAVICA (2021)

Related references

Note: Only part of the references are listed.

Article Medicine, Research & Experimental

Exosomes derived from miR-188-3p-modified adipose-derived mesenchymal stem cells protect Parkinson's disease

Qiang Li et al.

Summary: Parkinson's disease is the second most common neuro-degenerative disease characterized by irreversible damage of dopamine neurons. Studies have shown that NLRP3 inflammasome and CDK5-mediated autophagy are important in PD. miR-188-3p is a potential therapeutic target for treating PD.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Add to Collection

Article Clinical Neurology

Intravenous infusion of auto serum-expanded autologous mesenchymal stem cells in spinal cord injury patients: 13 case series

Osamu Honmou et al.

Summary: This study investigated the safety and feasibility of intravenous infusion of MSCs for spinal cord injury (SCI) patients, as well as the functional status after MSC infusion. Results showed no serious adverse events associated with MSC injection and improvements in neurological function and daily living ability in some patients after MSC infusion.

CLINICAL NEUROLOGY AND NEUROSURGERY (2021)

Add to Collection

Article Medicine, Research & Experimental

Hypothesis: Intravenous administration of mesenchymal stem cells is effective in the treatment of Alzheimer?s disease

Kazuo Shigematsu et al.

Summary: Researchers propose a new treatment for Alzheimer's disease using autologous adipose-derived stem cells administered intravenously, with the hypothesis that these stem cells can secrete neprilysin to break down and remove amyloid deposits in the brain. In addition to neprilysin secretion, stem cells have other mechanisms of action including nerve regeneration, repair, growth factor secretion, anti-inflammatory effects, and angiogenesis, making this treatment potentially effective and safe for patients. The hope is that this novel approach will bring hope to those suffering from Alzheimer's disease.

MEDICAL HYPOTHESES (2021)

Add to Collection

Article Cell & Tissue Engineering

Human acellular amniotic membrane incorporating exosomes from adipose-derived mesenchymal stem cells promotes diabetic wound healing

Shune Xiao et al.

Summary: The study demonstrated that hAAM scaffolds incorporated with ADSC-Exos can promote diabetic skin wound healing by regulating inflammation, stimulating vascularization, and promoting the production of extracellular matrix.

STEM CELL RESEARCH & THERAPY (2021)

Add to Collection

Letter Clinical Neurology

Re: Intravenous infusion of auto serum-expanded autologous mesenchymal stem cells in spinal cord injury patients: 13 case series

Kazuo Shigematsu et al.

CLINICAL NEUROLOGY AND NEUROSURGERY (2021)

Add to Collection

Letter Medicine, Research & Experimental

The mesenchymal stem cells will break down and remove the abnormal proteins that have become insoluble and deposited

Kazuo Shigematsu et al.

MEDICAL HYPOTHESES (2021)

Add to Collection

Article Multidisciplinary Sciences

Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson's disease

Daisuke Doi et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Engineering, Biomedical

iPS cell-based therapy for Parkinson's disease: A Kyoto trial

Jun Takahashi

Regenerative Therapy (2020)

Add to Collection

Review Neurosciences

Mesenchymal stem cells and neuroregeneration in Parkinson's disease

Aleksandra Glavaski-Joksimovic et al.

EXPERIMENTAL NEUROLOGY (2013)

Add to Collection

Article Neurosciences

Colonic inflammation in Parkinson's disease

David Devos et al.

NEUROBIOLOGY OF DISEASE (2013)

Add to Collection

Article Biochemistry & Molecular Biology

Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease

Hyun Jung Park et al.

JOURNAL OF NEUROCHEMISTRY (2008)

Add to Collection

Article Clinical Neurology

Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results

Christopher G. Goetz et al.

MOVEMENT DISORDERS (2008)

Add to Collection

Article Clinical Neurology

Movement disorder society task force report on the Hoehn and Yahr staging scale: Status and recommendations

CG Goetz et al.

MOVEMENT DISORDERS (2004)

Add to Collection

Article Clinical Neurology

Inflammation and neurodegeneration in Parkinson's disease

PL McGeer et al.

PARKINSONISM & RELATED DISORDERS (2004)

Add to Collection

Article Immunology

Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells

I Rasmusson et al.

TRANSPLANTATION (2003)

Add to Collection

Article Medicine, General & Internal

Transplantation of embryonic dopamine neurons for severe Parkinson's disease.

CR Freed et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.